Concepedia

Publication | Closed Access

Sustained Vertebral Fracture Risk Reduction After Withdrawal of Teriparatide in Postmenopausal Women With Osteoporosis

DOI

325

Citations

7

References

2004

Year

Robert Lindsay, Wim H. Scheele, Robert M. Neer, Gerhardt Pohl, Silvano Adami, C. Mautalén, Jean‐Yves Reginster, J Štěpán, Stephen L. Myers, Bruce Mitlak
Archives of Internal Medicine

Abstract

Vertebral fracture risk reduction by teriparatide administration persists for at least 18 months after discontinuation of therapy.

References

YearCitations

Page 1